Xavier Becerra's Vision for California Healthcare Reform
Xavier Becerra outlines his healthcare reform vision for California, advocating for a single-payer system and addressing urgent issues like fraud and healthcare access.
Trends in Diabetic Retinal Disease Among Diabetes Patients: Implications for Insurance
Analyze recent trends in diabetic retinal disease affecting patients and implications for insurance care models, risk management, and enhanced patient outcomes.
New Medicare ID Cards Issued by CMS to Combat Fraud
CMS is issuing new Medicare ID cards to 1.3 million beneficiaries by April 14, 2026, to enhance fraud protection and ensure healthcare access without service disruptions.
Impact of Federal Policies on the U.S. Care Economy
Explore the impact of federal policies on the U.S. care economy, highlighting the role of insurers, venture capital, and caregiving challenges.
Impact of MedPAC Recommendations on Physician Payment Rates
Explore the implications of MedPAC's recommendations on future Medicare payment rates for physicians, impacting independent practices and healthcare policy.
Proposed Changes Expediting Drug Approvals in Medicare and Medicaid
Discover proposed reforms to expedite drug approvals in Medicare and Medicaid. Learn how new electronic systems could streamline healthcare access.
Understanding Medicare Part B Premiums and IRMAA for Utah Retirees
Learn how Modified Adjusted Gross Income affects Medicare Part B premiums for Utah retirees and discover strategies to manage costs effectively.
Significant Changes in Pharmacy Regulations: Consolidated Appropriations Act 2026
Explore the impact of the Consolidated Appropriations Act 2026 on pharmacy regulations, enhancing transparency and oversight for PBMs and Medicare Part D.
Addressing Waste and Fraud in Government Health Programs
Join Brian Blase as he addresses waste, fraud, and improper payments in federal health programs at the National Press Club on April 28, featuring key speakers.
Impact of Generic Drugs and Biosimilars on Healthcare Costs
Explore the key impact of generic drugs and biosimilars on reducing prescription costs in the U.S. healthcare system, including legislative efforts and market dynamics.